Tony J Pircher
Overview
Explore the profile of Tony J Pircher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
246
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sweed N, Hsiao H, Blouw B, Pircher T, Fisher D, Naluz K, et al.
Arch Pathol Lab Med
. 2024 May;
149(3):242-252.
PMID: 38797516
Context.—: Leptomeningeal disease (LMD) is a clinical sequela of central nervous system metastasis involving the cerebrospinal fluid (CSF), often seen in late-stage solid tumors. It has a grave prognosis without...
2.
Mayer J, Pham T, Wong K, Scoggin J, Sales E, Clarin T, et al.
Cancer Genet
. 2011 Dec;
204(11):589-95.
PMID: 22200084
Determination of HER2 status in breast cancer patients is considered standard practice for therapy selection. However, tumor biopsy in patients with recurrent and/or metastatic disease is not always feasible. Thus,...
3.
Pecot C, Bischoff F, Mayer J, Wong K, Pham T, Bottsford-Miller J, et al.
Cancer Discov
. 2011 Dec;
1(7):580-6.
PMID: 22180853
Unlabelled: Metastasis is a complex, multistep process that begins with the epithelial-mesenchymal transition (EMT). Circulating tumor cells (CTC) are believed to have undergone EMT and thus lack or express low...
4.
Mikolajczyk S, Millar L, Tsinberg P, Coutts S, Zomorrodi M, Pham T, et al.
J Oncol
. 2011 May;
2011:252361.
PMID: 21577258
Enrichment of rare circulating tumor cells (CTCs) in blood is typically achieved using antibodies to epithelial cell adhesion molecule (EpCAM), with detection using cytokeratin (CK) antibodies. However, EpCAM and CK...